[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: جلد 8 - ::
برگشت به فهرست نسخه ها
The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream
:   (230 مشاهده)
The gene therapy approach has largely been improved by the development of new methods in gene transfer and genome editing. The use of CART cells was first approved in 2018 by FDA for ex vivo treatment of B cell acute lymphoblastic leukemia and in vivo treatment of retinal dystrophy. This revolutionary trend is expected to continue as the clinical vision develops and the technical capacity improves.
متن کامل [PDF 335 kb]   (91 دریافت)    
نوع مطالعه: Letters to the editor | موضوع مقاله: Other
دریافت: ۱۳۹۷/۱۲/۲۲ | پذیرش: ۱۳۹۸/۸/۱۸ | انتشار: ۱۳۹۸/۱۰/۱۱
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA



XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hasanzad M, Larijani B. The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream. Int J Mol Cell Med. 2019; 8 (S1) :69-70
URL: http://ijmcmed.org/article-1-1042-fa.html

The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream. مجله بین المللی سلولی و مولکولی. 1398; 8 (S1) :69-70

URL: http://ijmcmed.org/article-1-1042-fa.html



جلد 8 - برگشت به فهرست نسخه ها
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4071